The Manila Times

Addition Therapeutics Presents Preclinical Proof-of-Concept Data at American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting

Platform non-human primate (NHP) data demonstrate stable, durable protein expression enabled by all-RNA, LNP-based PRINT technologyPreclinical proof-of-concept rodent data being presented in multiple ...

BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP

CRP reductions in participants with obesity and elevated baseline inflammation BGE-102 was well tolerated across all dose levels Phase 2 proof-of-concept trial in cardiovascular risk planned to ...
Applied Clinical Trials Online

FDA Launches Proof-of-Concept Real-Time Clinical Trials

Early implementation of real-time clinical trial data sharing aims to reduce delays in safety signal detection and regulatory ...
News Medical

Centauri Therapeutics publishes proof-of-concept data demonstrating activity of a novel bifunctional immunotherapy against Gram-negative bacterial infections

Centauri Therapeutics Limited (Centauri), an immunotherapy company with a unique and proprietary platform technology applicable across a wide range of therapeutic indications, today announced the ...